Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-28 00:49:16 - browse：3333

A group of four doctors gather around a hologram projecting different medical icons — health tech coverage from STAT — Adobe

DarioHealth, which makes apps for managing chronic diseases, today announced it will acquire digital mental health company Twill for $10 million in cash plus stock valued at over $20 million at the end of Tuesday trading. The move is a bet that a consolidated offering can attract a critical mass of large customers in a market where profits have been elusive.

Founded in 2011, Dario started with a diabetes app targeted at consumers before expanding it to hypertension and weight management. It still maintains that direct-to-consumer business but has since shifted its focus to selling its suite of offerings, including a musculoskeletal care program it acquired in 2021, to health plans and employers in the hopes of reaching much larger patient populations. Recent updates aimed at making itself attractive to clients include a new offering built around popular, and expensive, GLP-1 weight loss drugs, and published real world data suggesting its tools can save clients money on downstream health care costs. With Twill, Dario adds a mental health app and related services, addressing a top demand of employers.

Despite momentum, DarioHealth, which is publicly traded, is unprofitable, and by its own estimations on earnings calls last year, it remained a ways from that milestone. Before acquiring Twill, the company said that it expected the whole business to break even at about $80 million in revenue — about four times the roughly $20 million it projected for 2023. In November, the company reported that it lost over $40 million in the first nine months of 2023.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Hottest summer in 2,000 years puts focus on extreme heat, health

WSS

STAT series 'Denied by AI' wins major journalism prizes

Abbott's new stent may help patients with peripheral artery disease

Problems with a popular proposal to regulate AI in health care

HHS suspends federal funding for EcoHealth Alliance

Devoted Health’s losses in Medicare Advantage persist

Lilly’s weekly insulin works as well as daily products, new studies show

Wikipedia

Wikipedia

explore

23andMe had bad news about my health. I wish a person had delivered it

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Cancer drug shortages should be causing more outrage

Updated Covid vaccine has 54% effectiveness, new study suggests

Novavax promises a turnaround & Lilly roils the obesity market

Bernie brings in new pharma CEOs to talk drug prices

Alkermes shareholders re

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

After affirmative action ruling, medical educators look to 'holistic review'

Devoted Health’s losses in Medicare Advantage persist

leisure time

A protest over insulin prices is seen as a fight for life

Free medical tuition alone isn't enough to close gaps in primary care

A protest over insulin prices is seen as a fight for life

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Oak Street deal isn't the answer to health care's woes

hotspot

hotspot

focus

focus